Genprex Inc. (NASDAQ: GNPX) Employs Trademarked Gene Therapy in Team-up to Fight Lung Cancer

Lung cancer is one of the most commonly occurring tumors in men and women, and it is the common cancer that’s most likely to result in death among all U.S. populations Genprex is advancing its trademarked Oncoprex immunogene therapy as a means of bolstering the body’s protein defenses against lung tumor growth Clinical trials for Oncoprex are evaluating ways to team it with other targeted therapies and immunotherapies to increase the overall efficacy of the therapies

The war on deadly cancers continues to advance innovative developments in the field of targeted therapies that block the growth of cancer cells by interfering with specific tumor-growing molecules (as opposed to chemotherapy, or cytotoxic therapy, which simply interferes with all rapidly dividing cells). Genprex Inc. (NASDAQ: GNPX) is at the forefront of the battle, testing its trademarked Oncoprex immunogene therapy as a means of combating lung cancers.

Lung cancer is one of the most commonly occurring cancers among all men and women in the United States, and it is the common cancer that’s most likely to result in death among men and…

Read More>>

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Latest News

Companies bracing for China's retaliation in tariffs dispute

May 24, 2019

BEIJING — Companies were bracing Monday for how Beijing might retaliate against President Donald Trump's escalation of a fight over technology and trade that threatens to disrupt a Chinese economic recovery. Regulators have threatened "necessary countermeasures" for Trump's tariff hikes Friday on $200 billion of Chinese imports. But three days later, in a break with previous tit-for-tat penalties that were imposed immediately, Beijing had yet to announce what it might do. A foreign ministry spokesman said Monday that he had no details about Chinese plans or high-level contacts since negotiations ended Friday without a deal. "We are determined and capable...

Singapore reportedly criminalizes publication of fake news

May 24, 2019

SINGAPORE — Singapore reportedly has passed a law criminalizing publication of fake news and allowing the government to block and order the removal of such content. The Protection from Online Falsehoods and Manipulation Bill passed Wednesday night by a vote of 72-9, a lawmaker with the opposition Worker's Party, Daniel Goh, said on Twitter. The law bans falsehoods that are prejudicial to Singapore or likely to influence elections and requires service providers to remove such content or allows the government to block it. Offenders could face a jail term of up to 10 years and hefty fines. Opponents in Parliament...

Experimental surgery gains support as opioid deaths rise

May 24, 2019

SHANGHAI — Patient Number One is a thin man, with a scabby face and bouncy knees. His head, shaved in preparation for surgery, is wrapped in a clean, white cloth. Years of drug use cost him his wife, his money and his self-respect, before landing him in this drab yellow room at a Shanghai hospital, facing the surgeon who in 72 hours will drill two small holes in his skull and feed electrodes deep into his brain. The hope is that technology will extinguish his addiction, quite literally, with the flip of a switch. The treatment — deep brain stimulation...

China's April exports fall amid US tariff war; imports rise

May 24, 2019

BEIJING — China's exports fell in April amid a punishing tariff war with Washington, adding to pressure on Beijing on the eve of negotiations aimed at settling the fight over its technology ambitions. Wednesday's announcement of trade data followed President Donald Trump's surprise threat of more tariff hikes on Chinese goods, which jolted global financial markets. April exports sank 2.7% from a year ago to $193.5 billion, a reverse from March's 14.2% growth, customs data showed. That was markedly weaker than private sector forecasts of growth in low single digits. Imports rose 4% to $179.6 billion, rebounding from the previous...

Chinese researchers try brain implants to treat drug addicts

May 24, 2019

SHANGHAI — The sound of doctors boring through his skull to feed electrodes deep into his brain made Yan tremble. "The drill was like bzzzzzzz," he later recalled. "The moment of drilling is the most terrible." Yan is a methamphetamine addict. The hope is that technology will extinguish his addiction — quite literally, with the flip of a switch. The treatment — deep brain stimulation — has long been used for movement disorders like Parkinson's. Now, the first clinical trial of DBS for methamphetamine addiction is being conducted at Shanghai's Ruijin Hospital, along with trials for opioid addicts. Yan is...

Search
Broaden

Scienfinite is created to inspire our readers with the aim to understand the world and appreciate its everyday awe. Keep up with the technology and latest innovations here, only in Scienfinite.

Contact us: sales@scienfinite.com